| An SI Board Since October 2004 |
| Posts |
SubjectMarks |
Bans |
Symbol |
| 5 |
0 |
0
|
DYX |
|
Company went public around 1995. Until recently its primary focus was OEM medical laboratory equipment, primarily urinalysis. It has changed managment within the last 18 months and has just begun rolling out aftermarket products including centrifuge tubes and various tests (Rapid tests and Elisa tests) for various diseases and markers. New regional sales managment were recently added. The company is also active in China. It is a potential turnaround situation although very risky, imo. Funding of recent/current operations has been through convertible loans from insiders and through equity line of credit - very little debt at this time. All time high was about $9.50. As of this writing it was trading below $0.50. Disclaimer: All the above is my opinion only. Not an investment recommendation. Do your own due diligence and decide for yourself.
|
|
|
